BMS-275291 in Treating Patients With HIV-Related Kaposi's Sarcoma
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I/II trial to study the effectiveness of BMS-275291 in treating patients who have
HIV-related Kaposi's sarcoma. Drugs such as BMS-275291 may stop the growth of Kaposi's
sarcoma by stopping blood flow to the tumor.